The global kidney stone management market size was valued at USD 1.7 billion in 2021 and is projected to surpass the value of USD 2.31 billion from 2022 to 2028 at a 7.12% CAGR during the forecast period.
Kidney Stone Management Market
The global kidney stone management market size was valued at USD 1.7 billion in 2021 and is projected to surpass the value of USD 2.31 billion from 2022 to 2028 at a 7.12% CAGR during the forecast period. The report analyzes the key aspects of the kidney stone management market like the drivers, restraints & challenges & their effects on the growth of the market during the projection period. This report will also enlist the opportunities in the Kidney stone management market
Kidney stone also known as urolithiasis/ renal calculi are caused when salts and minerals found in the kidney turn into hard deposits. The concentration of urine causes the minerals in the body to crystalize which then forms kidney stones. The reasons for kidney stones range from the usage of supplements to medications or excess body weight. Surgery to remove the kidney stone is needed when these hard deposits clog the urinary tract.
Techniques to treat kidney stones include Percutaneous Nephrolithotomy, Ureteroscopy, and Extracorporeal Shock Wave Lithotripsy (ESWL). However, the demand for minimally invasive techniques is higher in the global kidney stone management market. This technique will also help advance the current market scenario of kidney management.
Covid 19 has had a negative impact on the kidney stone management market growth. Since COVID 19, all nonessential surgery or medical procedures have taken a back seat. A lot of hospitals had to shut down their operations to curb the spread of Covid 19.
Reasons for the decrease in market growth can also be attributed to poor supply chain management, unavailability of raw materials, and slow economic growth.
The pervasiveness of kidney stones amongst the masses
The general pervasiveness of kidney stones amongst people of all age groups across the globe is a major driving factor for the market. The treatment of kidney stones with drugs has limited options and is less effective. Around 12% of the world’s population is predicted to be affected by kidney stones.
In countries like the USA and Canada, with a high standard of living, the prevalence rate of kidney stones is around 10%. Diseases like high blood pressure and diabetes lead to high chances of a person getting affected by kidney stones.
Minimal invasive operation techniques play an important role in the growth of the market
Currently, a lot of hospitals and the population, in general, prefer operational techniques which require minimal invasion. Minimal invasive techniques have fewer side effects than open surgeries. This trend of preference for minimally invasive techniques is likely to boost the demand for advanced technologies for treating kidney stones.
In the USA, as per the Journal of Advances in Chronic Kidney diseases, the following minimally invasive technique was preferred to treat stone diseases. They are extracorporeal shock wave lithotripsy, ureteroscopic lithotripsy, and percutaneous nephrolithotomy. This change in the market dynamic is a major contributing factor to increase demands in the global kidney stone management market.
Addition of advanced equipment to boost the kidney stone management market
A lot of big corporations are investing in research and development to launch newer and technically advanced equipment to assist in kidney stone management. For instance, Optivision technology developed by Dornier MedTech in 2019 is a great help in managing the outcome of stone treatment. Optivision is one of the first image processing software.
Negative effects of lithotripsy may hamper the growth of the kidney stone management market.
Although the prevalence of kidney stones is high globally, a lot of factors contribute to the lesser acceptance of its treatment. One of such reasons is the side effects related to lithotripsy. The side effects include bleeding around the kidneys, blockage of urine due to broken stones, several infections, and high arterial blood pressure to name a few.
As per a report generated by the American Journal of kidney diseases, shock wave lithotripsy may affect the functioning of kidneys and the reappearance of kidney stones.
In the current scenario, awareness related to kidney stones is much higher than it was in the previous years. The increase in awareness related to kidney stones will provide the necessary boost in the global kidney stone management market. The market development will also be affected positively because of the efforts taken by the government & big corporations in spreading the awareness related to the treatment of kidney stones.
Moreover, the advantages related to the early detection of kidney stones and their treatment will lead to a higher demand for nephrolithiasis.
Other opportunities in this market are related to the mergers & acquisitions of big players & launching of new products.
The challenges faced by the kidney stone management market are multifold. The foremost challenge faced by the market is the negative impact of Covid. All less critical medical cases had to take a back seat during Covid and one of them is cases related to kidney stones. Covid also had an impact on travel. The subsequent travel ban hampered the growth of the kidney stone management market.
Apart from this, the challenges faced by the market are fluctuations in supply & demand, and the non-availability of raw materials to manufacture the equipment needed to treat kidney stones.
Volatility in the stock market is another challenge faced by the market along with the falling of business assurances.
The global kidney stone management market is divided based on type, end-user, and region.
By Type Analysis:
The market is divided into 3 main segments based on the type: lithotripsy, ureteroscopy, & percutaneous Nephrolithotomy.
Out of these 3 types, the most well accepted is the ureteroscopy segment. It dominated the market in 2021. The main reasons are menial invasiveness along with a high success rate and low recurrence rate of kidney stones.
The ureteroscopy segment is expected to show an even higher CAGR in the forecasted period.
By End-user type:
Based on end-user, the segments are as follows: hospitals, specialty clinics & surgical centers. Out of these segments, the most dominant was the hospital segment. However, as per projected data, specialty clinics will be the segment with the highest market share during the forecasted period. Good reimbursement schemes with doctors specializing in kidney stone management as well as usage of advanced equipment will be the major driving factor for specialty clinics.
Regionally, North America is the largest contributor to the global kidney stone management market. The USA has state-of-the-art facilities, awareness amongst the population related to kidney stones is high, and per capita expenditure on healthcare is high.
This is followed by Europe where Germany and UK are the major contributors.
In Asia Pacific, India & China, two of the major developing countries are the main drivers of the kidney stone management market.
The major players in the global kidney stone management market which are currently dominating the industry are MorphoSys AG, Dyax Corp., Creative-biolabs, Abzena Plc., and AnaptysBio, Inc. Some of the other companies are Karl Storz GmbH & Co. Ltd., DirexGroup, Dornier MedTech, EDAP TMS, Lumenis Ltd., Elmed Medical System, Siemens Healthineers, Olympus Corporation, Cook Medical, and Boston Scientific Corporation
The pervasiveness of kidney stones amongst the global population is a leading factor of growth in the kidney stone management market. Other factors like the development of minimally invasive techniques and the development of advanced equipment are also key contributors to the kidney stone management market
According to Zion Market Research, the global kidney stone management market size was valued at USD 1.7 billion in 2021 and is projected to surpass the value of USD 2.31 billion from 2022 to 2028 at a 7.12% CAGR during the forecast period.
North America followed by Europe are the notable regions contributing toward kidney stone management market growth. The high standard of living and capability to spend significantly on healthcare are the key reasons for these regions to become key contributors. In Asia, developing countries like China and India will contribute significantly to the growth of the market.
The major player in the global kidney stone management market are MorphoSys AG, Dyax Corp., Creative-biolabs, Abzena Plc., and AnaptysBio, Inc. Some of the other companies are Karl Storz GmbH & Co. Ltd., DirexGroup, Dornier MedTech, EDAP TMS, Lumenis Ltd., Elmed Medical System, Siemens Healthineers, Olympus Corporation, Cook Medical, and Boston Scientific Corporation.